Caisse de depot et placement du Quebec

Position in HALO — Halozyme Therapeutics, Inc.

CIK 898286 Montreal, A8

Position in HALO

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$72,463,156

-$9,912,649 QoQ

Shares Held

1,121,200

-8.4% QoQ

Ownership

0.945%

of shares outstanding

% of Portfolio

0.12%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2024

7 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Caisse de depot et placement du Quebec holds $667,145,858 across 11 Biotechnology names. HALO ranks #4 (10.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	329,018	$254,212,467
2	INCY	Incyte Corp	1,520,486	$143,108,142
3	EXEL	Exelixis, Inc.	2,542,819	$109,061,506
4	HALO	Halozyme Therapeutics, Inc. This page	1,121,200	$72,463,156
5	BMRN	Biomarin Pharmaceutical Inc	945,603	$53,417,113
6	VRTX	Vertex Pharmaceuticals Inc / Ma	50,917	$22,736,477
7	RPRX	Royalty Pharma plc	218,031	$10,458,947
8	ALNY	Alnylam Pharmaceuticals, Inc.	1,988	$657,769

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$72,463,156	1,121,200	-8.4%	Shares	Sole	2026-05-14
2025-12-31	$82,375,805	1,224,009	+57.6%	Shares	Sole	2026-02-17
2025-09-30	$56,958,410	776,635	-42.1%	Shares	Sole	2025-11-14
2025-06-30	$69,770,264	1,341,220	+47.4%	Shares	Sole	2025-08-14
2025-03-31	$58,077,883	910,169	+154.5%	Shares	Sole	2025-05-14
2024-12-31	$17,095,851	357,579	+280.4%	Shares	Sole	2025-02-14
2024-09-30	$5,381,075	94,009	—	Shares	Sole	2024-11-14
No filing history on record for this holder in this stock.